Skip to content

HSA / FSA Eligible

Back to Blog
Hormones

Progesterone Deficiency: The Most Underdiagnosed Hormone Imbalance

March 18, 20269 min read

If you have ever been told your hormones are "normal" while dealing with crushing PMS, relentless anxiety, or cycles that just feel off, there is a good chance your progesterone levels have never been properly evaluated. Progesterone deficiency - sometimes called luteal phase deficiency - is one of the most common and most underdiagnosed hormone imbalances in women.

What Is Progesterone and Why Does It Matter?

Progesterone is a steroid hormone produced primarily by the corpus luteum in the ovary after ovulation. It plays a critical role in:

  • Preparing the uterine lining for potential implantation of a fertilized egg
  • Maintaining early pregnancy until the placenta takes over production
  • Calming the nervous system by acting on GABA receptors in the brain
  • Promoting restful sleep through its metabolite allopregnanolone
  • Balancing estrogen's effects on breast tissue, the uterine lining, and mood

Without adequate progesterone, estrogen goes relatively unopposed - a state often referred to as "estrogen dominance." This imbalance can drive a wide range of symptoms that are frequently attributed to stress, aging, or anxiety disorders rather than their true hormonal root cause.

Signs and Symptoms of Low Progesterone

Progesterone deficiency can manifest differently depending on your age, cycle phase, and overall hormonal landscape. Common signs include:

  • Severe PMS or PMDD: Mood swings, irritability, and depression in the luteal phase (the two weeks before your period)
  • Anxiety and restlessness: Progesterone is a natural anxiolytic; without it, your nervous system loses a key calming signal
  • Insomnia or disrupted sleep: Particularly in the second half of your cycle
  • Short luteal phase: Cycles where your period arrives less than 10 days after ovulation
  • Spotting before your period: Brown spotting for several days before full flow begins
  • Heavy or irregular periods: Unopposed estrogen can cause excessive endometrial buildup
  • Recurrent early miscarriage: Inadequate progesterone cannot sustain the uterine lining for implantation
  • Low libido: Progesterone contributes to overall hormonal equilibrium that supports desire
  • Breast tenderness and bloating: Classic signs of estrogen dominance

Luteal Phase Deficiency: The Clinical Picture

Luteal phase deficiency (LPD) occurs when the corpus luteum fails to produce enough progesterone after ovulation, or when the luteal phase is abnormally short (fewer than 10 days). This can happen due to:

  • Anovulatory cycles: If you do not ovulate, you do not produce a corpus luteum and therefore make very little progesterone
  • Chronic stress: Elevated cortisol can impair ovulation quality and progesterone output - a phenomenon sometimes called "pregnenolone steal"
  • Thyroid dysfunction: Both hypothyroidism and hyperthyroidism can disrupt ovulation
  • PCOS: Irregular ovulation is a hallmark feature
  • Perimenopause: Ovulation becomes inconsistent, leading to erratic progesterone production
  • Excessive exercise or undereating: Energy deficits suppress the hypothalamic-pituitary-ovarian axis

The Anxiety and Progesterone Connection

One of the most underappreciated roles of progesterone is its effect on the brain. Progesterone is converted to allopregnanolone, a neurosteroid that enhances GABA-A receptor activity - the same receptor targeted by anti-anxiety medications like benzodiazepines. When progesterone drops prematurely or is chronically low, women can experience significant anxiety, panic, and even depressive episodes, particularly in the luteal phase.

A 2014 study published in *Psychoneuroendocrinology* demonstrated that women with PMDD had altered sensitivity to allopregnanolone, suggesting that both low levels and abnormal receptor response can contribute to mood symptoms.

Progesterone, Sleep, and Insomnia

Progesterone has a mild sedative effect. Many women notice they sleep more deeply in the luteal phase when progesterone is at its peak. When levels are insufficient, insomnia - especially difficulty falling asleep and staying asleep - can become a recurring problem in the second half of the cycle.

Miscarriage Risk

Adequate progesterone is essential for maintaining the uterine lining during early pregnancy. A 2015 Cochrane review found that progesterone supplementation reduced miscarriage rates in women with recurrent pregnancy loss. Yet many women with a history of early miscarriage are never tested for luteal phase progesterone.

How to Test Progesterone: The Day 21 Test

Progesterone must be tested at the right time to be meaningful. Random progesterone levels are nearly useless because the hormone fluctuates dramatically across the menstrual cycle.

The gold standard is a mid-luteal phase blood draw - typically around day 21 of a 28-day cycle. More accurately, it should be drawn approximately 7 days after confirmed ovulation. If your cycles are longer or shorter than 28 days, the timing should be adjusted accordingly.

What the Numbers Mean

  • Below 1 ng/mL: Likely anovulatory - ovulation did not occur
  • 1-5 ng/mL: Ovulation may have occurred, but progesterone production is suboptimal
  • 5-10 ng/mL: Standard lab ranges may call this "normal," but many functional and reproductive medicine practitioners consider this suboptimal
  • 10-25 ng/mL: Generally considered a healthy mid-luteal progesterone level
  • Above 15 ng/mL: Often cited as the optimal range for conception and early pregnancy support

Important: Standard lab reference ranges often list anything above 1.8 ng/mL as "normal" for the luteal phase, which is misleadingly broad. A level of 3 ng/mL is technically within range but may be far too low for symptom resolution or pregnancy maintenance.

Lab Tests That Can Help

A comprehensive hormone evaluation should include more than just a single progesterone draw. The EllaDx Hormone & Longevity Panel and Fertility & Reproductive Panel include key markers for evaluating progesterone status in context:

  • Progesterone (mid-luteal, day 21 or 7 days post-ovulation)
  • Estradiol (to assess the estrogen-to-progesterone ratio)
  • LH and FSH (to evaluate ovulatory function)
  • Thyroid panel (TSH, Free T4, Free T3 - thyroid dysfunction impairs ovulation)
  • Cortisol (chronic stress suppresses progesterone production)
  • DHEA-S (adrenal contribution to hormonal balance)
  • Prolactin (elevated levels can suppress ovulation)

What You Can Do

If testing reveals low progesterone, there are evidence-based strategies to support healthy levels:

  • Reduce chronic stress: Cortisol and progesterone share a precursor (pregnenolone), and chronic stress can divert resources away from progesterone production
  • Ensure adequate nutrition: Zinc, vitamin B6, magnesium, and vitamin C all support progesterone synthesis
  • Address thyroid dysfunction: Optimal thyroid function is essential for regular ovulation
  • Consider bioidentical progesterone: Under medical supervision, oral or topical progesterone can be used to supplement deficient levels
  • Track your cycle: Basal body temperature tracking and ovulation predictor kits can help confirm whether and when ovulation is occurring

References

  • Prior, J. C. (2011). Progesterone for symptomatic perimenopause treatment - progesterone politics, physiology, and potential for perimenopause. *Facts, Views & Vision in ObGyn*, 3(2), 109-120.
  • Schiller, C. E., et al. (2014). Allopregnanolone as a mediator of affective switching in reproductive mood disorders. *Psychoneuroendocrinology*, 49, 62-71.
  • Coomarasamy, A., et al. (2015). A randomized trial of progesterone in women with recurrent miscarriages. *New England Journal of Medicine*, 373(22), 2141-2148.
  • Taraborrelli, S. (2015). Physiology, production and action of progesterone. *Acta Obstetricia et Gynecologica Scandinavica*, 94(S161), 8-14.
  • Barbieri, R. L. (2014). The endocrinology of the menstrual cycle. *Methods in Molecular Biology*, 1154, 145-169.
  • Monteleone, P., et al. (2000). Allopregnanolone concentrations and premenstrual syndrome. *European Journal of Endocrinology*, 142(3), 269-273.

Ready to get tested?

Take our symptom quiz to get personalized biomarker recommendations.

Take the Quiz

EllaDx